VEROVACCiNES GmbH-preview

Verovaccines

VEROVACCiNES GmbH

Private

Halle (Saale)Healthcare & Life Scienceshttps://verovaccines.com

Last Round

Early Funding

Feb 25, 2025

Total Funding Raised

$5.49M

Company Overview

VEROVACCiNES GmbH is a German biopharmaceutical company that develops innovative, yeast-based subunit vaccines for animal health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

animal healthlivestock vaccinesrecombinant subunit vaccinesyeast-based vaccinesvaccine platformthermostable vaccinesmultivalent vaccinescold chain free vaccinesveterinary vaccinesKluyveromyces lactis platformvaccine developmentanimal pharmaBTV-3 vaccineBluetongue virus vaccinetechnology licensingco-development partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VEROVACCiNES GmbH Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

VEROVACCiNES GmbH Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Early Funding	Feb 25, 2025
Series B	Oct 14, 2021
Grant	Apr 17, 2018
Seed	Dec 1, 2017

View all Funding Rounds

Key People

Founding team and executive leadership

Hanjo Hennemann

Co-founder CEO

Founding Team

VEROVACCiNES GmbH Investors

Notable investors and investment history

Investor	Rounds
High-Tech Gründerfonds	Early Funding, Seed
Founders	Early Funding

View all Investors

VEROVACCiNES GmbH Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

VEROVACCiNES GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VEROVACCiNES GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersHalle (Saale)

Employee Range10

Year Founded2017

Last FundingFeb 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.